FDx Advisors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-4,348
| Closed | -$489K | – | 1101 |
|
|
2018
Q1 | $489K | Buy |
4,348
+3
| +0.1% | +$337 | 0.01% | 781 |
|
|
2017
Q4 | $643K | Sell |
4,345
-363
| -8% | -$53.7K | 0.02% | 701 |
|
|
2017
Q3 | $552K | Sell |
4,708
-168
| -3% | -$19.7K | 0.02% | 760 |
|
|
2017
Q2 | $633K | Sell |
4,876
-538
| -10% | -$69.8K | 0.02% | 684 |
|
|
2017
Q1 | $733K | Sell |
5,414
-572
| -10% | -$77.4K | 0.02% | 633 |
|
|
2016
Q4 | $859K | Buy |
5,986
+52
| +0.9% | +$7.46K | 0.02% | 572 |
|
|
2016
Q3 | $701K | Buy |
5,934
+1,026
| +21% | +$121K | 0.03% | 503 |
|
|
2016
Q2 | $520K | Sell |
4,908
-57
| -1% | -$6.04K | 0.02% | 581 |
|
|
2016
Q1 | $553K | Buy |
4,965
+1,048
| +27% | +$117K | 0.03% | 547 |
|
|
2015
Q4 | $613K | Buy |
3,917
+224
| +6% | +$35.1K | 0.03% | 495 |
|
|
2015
Q3 | $485K | Buy |
3,693
+48
| +1% | +$6.3K | 0.04% | 455 |
|
|
2015
Q2 | $626K | Buy |
3,645
+245
| +7% | +$42.1K | 0.03% | 498 |
|
|
2015
Q1 | $579K | Sell |
3,400
-1,615
| -32% | -$275K | 0.01% | 870 |
|
|
2014
Q4 | $649K | Sell |
5,015
-3,112
| -38% | -$403K | 0.04% | 454 |
|
|
2014
Q3 | $1.05M | Buy |
8,127
+442
| +6% | +$56.9K | 0.07% | 317 |
|
|
2014
Q2 | $680K | Buy |
7,685
+1,944
| +34% | +$172K | 0.04% | 471 |
|
|
2014
Q1 | $540K | Buy |
+5,741
| New | +$540K | 0.05% | 418 |
|
|
2013
Q4 | – | Sell |
-3,600
| Closed | -$284K | – | 670 |
|
|
2013
Q3 | $284K | Buy |
3,600
+118
| +3% | +$9.31K | 0.03% | 459 |
|
|
2013
Q2 | $229K | Buy |
+3,482
| New | +$229K | 0.03% | 450 |
|